PANCREATIC INSUFFICIENCY AND PULMONARY-DISEASE IN GERMAN AND SLAVIC CYSTIC-FIBROSIS PATIENTS WITH THE R347P MUTATION

被引:11
|
作者
VARON, R
STUHRMANN, M
MACEK, M
KUFARDJIEVA, A
ANGELICHEVA, D
MAGDORF, K
JORDANOVA, A
SAVOV, A
WAHN, U
MACEK, M
LALOV, V
IVANOVA, T
ELLEMUNTER, H
VAVROVA, V
FERAK, V
KAYSEROVA, H
REIS, A
KALAYDJIEVA, L
机构
[1] FREE UNIV BERLIN, INST HUMAN GENET, D-14059 BERLIN, GERMANY
[2] MHH, INST HUMAN GENET, D-30625 HANNOVER, GERMANY
[3] JOHNS HOPKINS MED INST, CTR MED GENET, BALTIMORE, MD 21287 USA
[4] UNIV SOFIA, CHILDRENS HOSP, BU-1126 SOFIA, BULGARIA
[5] UNIV SOFIA, OBSTET & GYNAECOL HOSP, MOLEC PATHOL LAB, BU-1431 SOFIA, BULGARIA
[6] FREE UNIV BERLIN, CHILDRENS HOSP, D-14059 BERLIN, GERMANY
[7] UNIV INNSBRUCK, CHILDRENS HOSP, DEPT CYST FIBROSIS, A-6020 INNSBRUCK, AUSTRIA
[8] CHARLES UNIV, FN MOTOL, DEPT MED GENET 2, PRAGUE 5, CZECH REPUBLIC
[9] CHARLES UNIV, FN MOTOL, PEDIAT CLIN, PRAGUE 5, CZECH REPUBLIC
[10] SLOVAK ACAD SCI, INST MOLEC PHYSIOL & GENET, BRATISLAVA 83334, SLOVAKIA
[11] DETER HOSP, BRATISLAVA, SLOVAKIA
[12] BURGAS REG HOSP, GENET COUNSELLING UNIT, BU-5000 BURGAS, BULGARIA
关键词
PANCREATIC INSUFFICIENCY; PULMONARY DISEASE; CYSTIC FIBROSIS; R347P MUTATION;
D O I
10.1002/humu.1380060304
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cystic fibrosis (CF) is caused by mutations in the gene for the cystic fibrosis transmembrane conductance regulator (CFTR) that codes for a cAMP-regulated chloride channel, The R347P is a missense mutation located within the first membrane spanning domain (MSD1) of the CFTR protein. This mutation occurs with an overall worldwide frequency of about 0.2%. The patients, originally described with this mutation were compound heterozgotes with the Delta F508 mutation and had a very mild course of CF, suggesting that R347P, similar to other missense mutations affecting the MSD1 domain, causes a mild phenotype. We report here a group of 19 CF patients with the R347P mutation of German, Bulgarian, Czech, and Slovak origin, including two homozygotes. Most patients presented with early disease onset, pancreas insufficiency (PI), and early pulmonary involvement, suggesting that this mutation can lead to a severe course of CF. Most R347P alleles in the group studied share a common polymorphic haplotype. In addition, these analyses gave evidence for recurrence of the mutation in two CF patients of German and Czech origin. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 9 条
  • [1] GASTROESOPHAGEAL REFLUX AND SEVERITY OF PULMONARY-DISEASE IN CYSTIC-FIBROSIS
    GUSTAFSSON, PM
    FRANSSON, SG
    KJELLMAN, NIM
    TIBBLING, L
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 (05) : 449 - 456
  • [2] EVALUATION OF LONG-TERM TOBRAMYCIN THERAPY IN PATIENTS WITH CYSTIC-FIBROSIS AND ADVANCED PULMONARY-DISEASE
    PAPORISZ, U
    POSSELT, HG
    WONNE, R
    RISTOW, W
    ROSER, D
    KNOTHE, H
    BENDER, SW
    EUROPEAN JOURNAL OF PEDIATRICS, 1979, 130 (04) : 259 - 269
  • [3] ATOPIC CHILDREN WITH CYSTIC-FIBROSIS HAVE INCREASED URINARY LEUKOTRIENE E(4) CONCENTRATIONS AND MORE SEVERE PULMONARY-DISEASE
    GREALLY, P
    COOK, AJ
    SAMPSON, AP
    COLEMAN, R
    CHAMBERS, S
    PIPER, PJ
    PRICE, JF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 100 - 107
  • [4] Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency
    Khodadad, Ahmad
    Elahi, Elaheh
    Hassani, Setareh Sadat Bani
    Rouhani, Pejman
    Sadeghi, Bamdad
    Rezaei, Nima
    IRANIAN JOURNAL OF PEDIATRICS, 2015, 25 (06)
  • [5] A cystic fibrosis patient homozygous for 621+1G->T mutation has a severe pulmonary disease, mild pancreatic insufficiency and a gastro-esophageal reflux
    Witt, M
    Pogorzelski, A
    Zebrak, J
    Rutkiewicz, E
    CLINICAL GENETICS, 1996, 50 (03) : 149 - 151
  • [6] Modeling cystic fibrosis disease progression in patients with the rare CFTR mutation P67L
    MacKenzie, Isobel E. R.
    Paquette, Valerie
    Gosse, Frances
    George, Sheenagh
    Chappe, Frederic
    Chappe, Valerie
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (03) : 335 - 341
  • [7] RECOMBINANT HUMAN DNASE-I IN CYSTIC-FIBROSIS PATIENTS WITH SEVERE PULMONARY-DISEASE - A SHORT-TERM, DOUBLE-BLIND-STUDY FOLLOWED BY 6 MONTHS OPEN-LABEL TREATMENT
    SHAH, PI
    BUSH, A
    CANNY, GJ
    COLIN, AA
    FUCHS, HJ
    GEDDES, DM
    JOHNSON, CAC
    LIGHT, MC
    SCOTT, SF
    TULLIS, DE
    DEVAULT, A
    WOHL, ME
    HODSON, ME
    EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (06) : 954 - 958
  • [8] Thirteen cystic fibrosis patients, 12 compound heterozygous and one homozygous for the missense mutation G85E: A pancreatic sufficiency insufficiency mutation with variable clinical presentation
    Vazquez, C
    Antinolo, G
    Casals, T
    Dapena, J
    Elorz, J
    Seculi, JL
    Sirvent, J
    Cabanas, R
    Soler, C
    Estivill, X
    JOURNAL OF MEDICAL GENETICS, 1996, 33 (10) : 820 - 822
  • [9] Spectrum of CFTR gene mutations in Ecuadorian cystic fibrosis patients: the second report of the p.H609R mutation
    Ortiz, Sofia C.
    Aguirre, Santiago J.
    Flores, Sofia
    Maldonado, Claudio
    Mejia, Juan
    Salinas, Lilian
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2017, 5 (06): : 751 - 757